{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:19:08Z","timestamp":1740143948308,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ejection time (ET), acceleration time (AT) and time between left ventricular and aortic systolic pressure peaks (T-LVAo) might be of diagnostic and prognostic use in patients with aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>We aimed to assess the diagnostic value and prognostic impact of invasively measured ET, AT, and T-LVAo in patients undergoing TAVI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 1274 patients received invasive measurement of ET, AT and T-LVAo prior to TAVI. Anatomic AS severity was assessed by CT-derived aortic valve calcification density (AVC<jats:sub>d<\/jats:sub>). Impact on all-cause mortality was retrospectively analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In multivariable linear regression, T-LVAo showed the strongest correlation with AVC<jats:sub>d<\/jats:sub>. No prognostic impact of T-LVAo was found according to uni- and multivariable analyses. In contrast, using an individual <jats:italic>C<\/jats:italic>-statistic derived cutoff (<jats:italic>C<\/jats:italic><jats:sub>D<\/jats:sub>), patients with ET or AT\u2009\u2265\u2009<jats:italic>C<\/jats:italic><jats:sub>D<\/jats:sub> showed lower mortality rates compared to patients with ET or AT\u2009&lt;\u2009<jats:italic>C<\/jats:italic><jats:sub>D<\/jats:sub> (1-year mortality: ET\u2009\u2265\u2009vs.\u2009&lt;\u2009<jats:italic>C<\/jats:italic><jats:sub>D<\/jats:sub>: 15.01vs. 33.1%, AT\u2009\u2265\u2009vs\u2009&lt;\u2009<jats:italic>C<\/jats:italic><jats:sub>D<\/jats:sub> 16.3 vs. 26.5%, <jats:italic>p\u2009&lt;\u2009<\/jats:italic>0.001). Moreover, multivariable analysis identified ET\u2009\u2265\u2009<jats:italic>C<\/jats:italic><jats:sub>D<\/jats:sub> (HR 0.61 [95% CI 0.43\u20130.87; <jats:italic>p\u2009&lt;\u2009<\/jats:italic>0.007]) to be associated with beneficial outcome after TAVI, independent from clinical risk factors and echocardiography-derived parameters.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Among the studied hemodynamic parameters T-LVAo provides the highest diagnostic value, whereas ET is an outcome predictor beyond clinical risk factors and echocardiographic parameters in AS patients following TAVI. These parameters could be of considerable use in diagnostic evaluation and risk assessment of patients scheduled for TAVI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n                <jats:p>T-LVAo (yellow): defined as time between left ventricular and aortic systolic pressure peaks. ET (green): Ejection Time defined as time from the start to flow end. AT (orange): Acceleration time defined as time from the start to the peak flow. AOP: aortic pressure, AVC: aortic valve calcification, CI: confidence interval, HGAS: high-gradient aortic stenosis, LGAS: low-gradient aortic stenosis, LVP: left ventricular pressure, SD: standard deviation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00392-023-02154-y","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T07:45:02Z","timestamp":1674114302000},"page":"667-676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic impact and diagnostic value of invasively derived hemodynamic measures in patients with severe aortic stenosis undergoing TAVI"],"prefix":"10.1007","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8100-7594","authenticated-orcid":false,"given":"David","family":"Grundmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Go\u00dfling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lennard","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Voigtlaender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Linder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Waldschmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Till","family":"Demal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver D.","family":"Bhadra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Reichenspurner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Blankenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenard","family":"Conradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Westermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritz","family":"Seiffert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklas","family":"Schofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,19]]},"reference":[{"key":"2154_CR1","doi-asserted-by":"publisher","first-page":"e443","DOI":"10.1016\/j.ijcard.2013.12.318","volume":"172","author":"SH Kim","year":"2014","unstructured":"Kim SH, Kim JS, Kim BS et al (2014) Time to peak velocity of aortic flow is useful in predicting severe aortic stenosis. Int J Cardiol 172:e443\u2013e446. https:\/\/doi.org\/10.1016\/j.ijcard.2013.12.318","journal-title":"Int J Cardiol"},{"key":"2154_CR2","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.echo.2017.06.001","volume":"30","author":"S Gamaza-Chuli\u00e1n","year":"2017","unstructured":"Gamaza-Chuli\u00e1n S, D\u00edaz-Retamino E, Camacho-Freire S et al (2017) Acceleration time and ratio of acceleration time to ejection time in aortic stenosis: new echocardiographic diagnostic parameters. J Am Soc Echocardiogr 30:947\u2013955. https:\/\/doi.org\/10.1016\/j.echo.2017.06.001","journal-title":"J Am Soc Echocardiogr"},{"key":"2154_CR3","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jcmg.2011.08.012","volume":"4","author":"S Ben Zekry","year":"2011","unstructured":"Ben Zekry S, Saad RM, Zkan M et al (2011) Flow acceleration time and ratio of acceleration time to ejection time for prosthetic aortic valve function. JACC Cardiovasc Imaging 4:1161\u20131170. https:\/\/doi.org\/10.1016\/j.jcmg.2011.08.012","journal-title":"JACC Cardiovasc Imaging"},{"key":"2154_CR4","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003907","author":"D Kamimura","year":"2016","unstructured":"Kamimura D, Hans S, Suzuki T et al (2016) Delayed time to peak velocity is useful for detecting severe aortic stenosis. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.116.003907","journal-title":"J Am Heart Assoc"},{"key":"2154_CR5","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1001\/jamacardio.2019.1180","volume":"4","author":"K Sato","year":"2019","unstructured":"Sato K, Kumar A, Jobanputra Y et al (2019) Association of time between left ventricular and aortic systolic pressure peaks with severity of aortic stenosis and calcification of aortic valve. JAMA Cardiol 4:549\u2013555. https:\/\/doi.org\/10.1001\/jamacardio.2019.1180","journal-title":"JAMA Cardiol"},{"key":"2154_CR6","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/eurheartj\/ehaa799","volume":"42","author":"P G\u00e9n\u00e9reux","year":"2021","unstructured":"G\u00e9n\u00e9reux P, Piazza N, Alu MC et al (2021) Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. Eur Heart J 42:1825\u20131857. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa799","journal-title":"Eur Heart J"},{"key":"2154_CR7","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/ehjci\/jev174","volume":"17","author":"M Seiffert","year":"2016","unstructured":"Seiffert M, Fujita B, Avanesov M et al (2016) Device landing zone calcification and its impact on residual regurgitation after transcatheter aortic valve implantation with different devices. Eur Heart J Cardiovasc Imaging 17:576\u2013584. https:\/\/doi.org\/10.1093\/ehjci\/jev174","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2154_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ahj.2020.03.013","volume":"225","author":"S Ludwig","year":"2020","unstructured":"Ludwig S, Go\u00dfling A, Waldschmidt L et al (2020) TAVR for low-flow, low-gradient aortic stenosis: Prognostic impact of aortic valve calcification. Am Heart J 225:138\u2013148. https:\/\/doi.org\/10.1016\/j.ahj.2020.03.013","journal-title":"Am Heart J"},{"key":"2154_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab395","author":"A Vahanian","year":"2021","unstructured":"Vahanian A, Beyersdorf F, Praz F et al (2021) 2021 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehab395","journal-title":"Eur Heart J"},{"key":"2154_CR10","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.amjcard.2019.07.064","volume":"124","author":"A Altes","year":"2019","unstructured":"Altes A, Thellier N, Bohbot Y et al (2019) Prognostic impact of the ratio of acceleration time to ejection time in patients with gradient severe aortic stenosis and preserved ejection fraction. Am J Cardiol 124:1594\u20131600. https:\/\/doi.org\/10.1016\/j.amjcard.2019.07.064","journal-title":"Am J Cardiol"},{"key":"2154_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.echo.2017.11.015","volume":"31","author":"A Ringle Griguer","year":"2018","unstructured":"Ringle Griguer A, Tribouilloy C, Truffier A et al (2018) Clinical significance of ejection dynamics parameters in patients with aortic stenosis: an outcome study. J Am Soc Echocardiogr 31:551-560.e2. https:\/\/doi.org\/10.1016\/j.echo.2017.11.015","journal-title":"J Am Soc Echocardiogr"},{"key":"2154_CR12","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jacc.2014.05.066","volume":"64","author":"MA Clavel","year":"2014","unstructured":"Clavel MA, Pibarot P, Messika-Zeitoun D et al (2014) Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. J Am Coll Cardiol 64:1202\u20131213. https:\/\/doi.org\/10.1016\/j.jacc.2014.05.066","journal-title":"J Am Coll Cardiol"},{"key":"2154_CR13","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/ccd.27124","volume":"90","author":"G Witberg","year":"2017","unstructured":"Witberg G, Finkelstein A, Barbash I et al (2017) Prognostic significance of aortic valve gradient in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Catheter Cardiovasc Interv 90:1175\u20131182. https:\/\/doi.org\/10.1002\/ccd.27124","journal-title":"Catheter Cardiovasc Interv"},{"key":"2154_CR14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jcct.2017.07.004","volume":"11","author":"J Boulif","year":"2017","unstructured":"Boulif J, Gerber B, Slimani A et al (2017) Assessment of aortic valve calcium load by multidetector computed tomography. Anatomical validation, impact of scanner settings and incremental diagnostic value. J Cardiovasc Comput Tomogr 11:360\u2013366. https:\/\/doi.org\/10.1016\/j.jcct.2017.07.004","journal-title":"J Cardiovasc Comput Tomogr"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02154-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-023-02154-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02154-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T11:02:35Z","timestamp":1687431755000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-023-02154-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,19]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["2154"],"URL":"https:\/\/doi.org\/10.1007\/s00392-023-02154-y","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"type":"print","value":"1861-0684"},{"type":"electronic","value":"1861-0692"}],"subject":[],"published":{"date-parts":[[2023,1,19]]},"assertion":[{"value":"22 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M. Linder, L. Voigtl\u00e4nder, and O.D. Bhadra have received travel compensation from Edwards Lifesciences. S. Ludwig has recieved travel compensation from Edwards Lifesciences and honoraria from Bayer. M. Seiffert reports personal fees and non-financial support from Abbott Vascular, personal fees from Abiomed, AstraZeneca, Bayer Healthcare, Boehringer Ingelheim, Bristol-Myers Squibb, Medtronic, Amgen, Shockwave Medical, Dachii Sankyo, Pfizer, Siemens Healthineers, Inari Medical, grants, personal fees and non-financial support from Boston Scientific, personal fees and non-financial support from Edwards Lifesciences, grants and personal fees from Philips, outside the submitted work. N. Schofer has received speaker honoraria, proctor fees and travel compensation from Edwards Lifesciences and St. Jude Medical, as well as speaker honoraria and travel compensation from Boston Scientific. L. Conradi is a proctor for and has received speaker honoraria as well as travel compensation from JenaValve, Edwards Lifesciences and Boston Scientific, has received speaker honoraria and travel compensation from Medtronic and is a consultant for Edwards Lifesciences. D. Westermann has received honoraria from AstraZeneca, Bayer, B\u00f6hringer-Ingelheim, Berlin Chemie, Novartis and Medtronic. A. Schaefer has received travel compensation from Edwards Lifesciences and speaker honoraria from Abbott. The other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All scientific research in this study has been approved by the appropriate ethics committee and has, therefore, been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}